These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7979494)

  • 1. Influence of spacer device on drug delivery to young children with asthma.
    Agertoft L; Pedersen S
    Arch Dis Child; 1994 Sep; 71(3):217-9; discussion 219-20. PubMed ID: 7979494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How much nebulised budesonide reaches infants and toddlers?
    Lødrup Carlsen KC; Nikander K; Carlsen KH
    Arch Dis Child; 1992 Sep; 67(9):1077-9. PubMed ID: 1417048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
    Agertoft L; Pedersen S; Nikander K
    J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalational drug delivery from seven different spacer devices.
    Barry PW; O'Callaghan C
    Thorax; 1996 Aug; 51(8):835-40. PubMed ID: 8795674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler.
    Barry PW; O'Callaghan C
    Br J Clin Pharmacol; 1995 Jul; 40(1):76-8. PubMed ID: 8527272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-electrostatic spacer for aerosol delivery.
    Bisgaard H; Anhøj J; Klug B; Berg E
    Arch Dis Child; 1995 Sep; 73(3):226-30. PubMed ID: 7492160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of budesonide in severe asthmatics aged 1-3 years.
    Connett GJ; Warde C; Wooler E; Lenney W
    Arch Dis Child; 1993 Sep; 69(3):351-5. PubMed ID: 8215545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life.
    Janssens HM; Devadason SG; Hop WC; LeSouëf PN; De Jongste JC; Tiddens HA
    Eur Respir J; 1999 Apr; 13(4):787-91. PubMed ID: 10362041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of the inhalation device on the effect of budesonide.
    Agertoft L; Pedersen S
    Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy and tolerance of terbutaline and budesonide administered via a pressurized aerosol inhaler or a Turbohaler in asthmatic patients].
    Zellweger JP; Anderhub HP; Langloh P
    Schweiz Rundsch Med Prax; 1993 May; 82(19):561-4. PubMed ID: 8506434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children.
    Pedersen S
    J Aerosol Med; 1994; 7(Suppl 1):S67-71. PubMed ID: 10147083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.
    Agertoft L; Pedersen S
    Respir Med; 1994 May; 88(5):373-81. PubMed ID: 8036306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of asthma: research on the minimum effective dose of inhaled corticoids. Results with budesonide].
    Malka M
    Rev Med Interne; 1994; 15 Suppl 2():252s-3s. PubMed ID: 8079078
    [No Abstract]   [Full Text] [Related]  

  • 16. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metal aerosol holding chamber devised for young children with asthma.
    Bisgaard H
    Eur Respir J; 1995 May; 8(5):856-60. PubMed ID: 7656962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metered dose inhaler add-on devices: is the inhaled mass of drug dependent on the size of the infant?
    Turpeinen M; Nikander K; Malmberg LP; Pelkonen A
    J Aerosol Med; 1999; 12(3):171-6. PubMed ID: 10623333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled budesonide for chronic wheezing under 18 months of age.
    Noble V; Ruggins NR; Everard ML; Milner AD
    Arch Dis Child; 1992 Mar; 67(3):285-8. PubMed ID: 1575550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The output of budesonide from spacer devices assessed under simulated breathing conditions.
    Barry PW; O'Callaghan C
    J Allergy Clin Immunol; 1999 Dec; 104(6):1205-10. PubMed ID: 10589002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.